User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 7 results.
    • Journal article
    Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: analyses of the phase II adrenomedullin and outcome in septic shock 2 trial.
    van Lier, Dirk Picod, Adrien Marx, Gernot Laterre, Pierre-François[UCL] Hartmann, Oliver Knothe, Claudia Azibani, Feriel Struck, Joachim Santos, Karine Zimmerman, Jens Bergmann, Andreas Mebazaa, Alexandre Pickkers, Peter (2022) Frontiers in medicine — Vol. 9, p. 1058235 [1-11] (2022)
    • Journal article
    Bioactive Adrenomedullin, Organ Support Therapies, and Survival in the Critically Ill: Results from the French and European Outcome Registry in ICU Study.
    Lemasle, Léa Blet, Alice Geven, Christopher Cherifa, Ményssa Deniau, Benjamin Hollinger, Alexa Fournier, Marie-Céline Monnet, Xavier Rennuit, Isabelle Darmon, Michael Laterre, Pierre-François[UCL] Struck, Joachim Hartmann, Oliver Bergmann, Andreas Mebazaa, Alexandre Gayat, Etienne (2020) Critical care medicine — Vol. 48, no.1, p. 49-55 (2020)
    • Journal article
    Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study.
    Blet, Alice Deniau, Benjamin Santos, Karine van Lier, Dirk P T Azibani, Feriel Wittebole, Xavier[UCL] Chousterman, Benjamin G Gayat, Etienne Hartmann, Oliver Struck, Joachim Bergmann, Andreas Antonelli, Massimo Beishuizen, Albertus Constantin, Jean-Michel Damoisel, Charles Deye, Nicolas Di Somma, Salvatore Dugernier, Thierry François, Bruno Gaudry, Stephane Huberlant, Vincent Lascarrou, Jean-Baptiste Marx, Gernot Mercier, Emmanuelle Oueslati, Haikel Pickkers, Peter Sonneville, Romain Legrand, Matthieu Laterre, Pierre-François[UCL] Mebazaa, Alexandre AdrenOSS-1 Study Investigators (2021) Critical care — Vol. 25, no.1, p. 61 [1-10] (2021)
    • Journal article
    Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.
    Mebazaa, Alexandre Geven, Christopher Hollinger, Alexa Wittebole, Xavier[UCL] Chousterman, Benjamin Glen Blet, Alice Gayat, Etienne Hartmann, Oliver Scigalla, Paul Struck, Joachim Bergmann, Andreas Antonelli, Massimo Beishuizen, Albertus Constantin, Jean-Michel Damoisel, Charles Deye, Nicolas Di Somma, Salvatore Dugernier, Thierry François, Bruno Gaudry, Stephane Huberlant, Vincent Lascarrou, Jean-Baptiste Marx, Gernot Mercier, Emmanuelle Oueslati, Haikel Pickkers, Peter Sonneville, Romain Legrand, Matthieu Laterre, Pierre-François[UCL] AdrenOSS-1 study investigators (2018) Critical Care — Vol. 22, no.1, p. 354 (2018)
    • Journal article
    Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study.
    Hollinger, Alexa Wittebole, Xavier[UCL] François, Bruno Pickkers, Peter Antonelli, Massimo Gayat, Etienne Chousterman, Benjamin Glen Lascarrou, Jean-Baptiste Dugernier, Thierry Di Somma, Salvatore Struck, Joachim Bergmann, Andreas Beishuizen, Albertus Constatin, Jean-Michel Damoisel, Charles Deye, Nicolas Gaudry, Stéphane Huberlant, Vincent Marx, Gernot Mercier, Emanuelle Oueslati, Haikel Hartmann, Oliver Sonneville, Romain Laterre, Pierre-François[UCL] Mebazaa, Alexandre Legrand, Matthieu (2018) Kidney International Reports — Vol. 3, no.6, p. 1424-1433 (2018)
    • Journal article
    Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure.
    Mebazaa, Alexandre Laterre, Pierre-François[UCL] Russell, James A Bergmann, Andreas Gattinoni, Luciano Gayat, Etienne Harhay, Michael O Hartmann, Oliver Hein, Frauke Kjolbye, Anne Louise Legrand, Matthieu Lewis, Roger J Marshall, John C Marx, Gernot Radermacher, Peter Schroedter, Mathias Scigalla, Paul Stough, Wendy Gattis Struck, Joachim Van den Berghe, Greet Yilmaz, Mehmet Birhan Angus, Derek C (2016) Journal of intensive care — Vol. 4, no. 1, p. 24 [1-11] (2016)
    • Journal article
    Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
    Laterre, Pierre-François[UCL] Pickkers, Peter Marx, Gernot Wittebole, Xavier[UCL] Meziani, Ferhat Dugernier, Thierry Huberlant, Vincent Schuerholz, Tobias François, Bruno Lascarrou, Jean-Baptiste Beishuizen, Albertus Oueslati, Haikel Contou, Damien Hoiting, Oscar Lacherade, Jean-Claude Chousterman, Benjamin Pottecher, Julien Bauer, Michael Godet, Thomas Karakas, Mahir Helms, Julie Bergmann, Andreas Zimmermann, Jens Richter, Kathleen Hartmann, Oliver Pars, Melanie Mebazaa, Alexandre AdrenOSS-2 study participants Castanares Zapatero, Diego[UCL] Collienne, Christine[UCL] Gérard, Ludovic[UCL] Hantson, Philippe[UCL] Montiel, Virginie[UCL] Berghe, Caroline[UCL] Dujardin, Marie-France[UCL] Gielens, Leslie[UCL] Renard, Suzanne[UCL] (2021) Intensive care medicine — Vol. 47, no.11, p. 1284-1294 (2021)